Related Experiment Video
Updated: Sep 30, 2025
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Identification of gut microbiome and transcriptome changes in ulcerative colitis and pouchitis
Xin Gao1,2, Di Huang1,3, Li-Sheng Yang4
1Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Pouchitis and ulcerative colitis (UC) exhibit distinct gut microbial and gene expression profiles. These differences suggest pouchitis may develop through a unique disease pathway separate from UC.
Area of Science:
- Gastroenterology
- Microbiology
- Genomics
Background:
- Pouchitis is a frequent complication following surgery for ulcerative colitis (UC).
- Both pouchitis and UC are considered forms of inflammatory bowel disease.
- Understanding their differences is crucial for targeted treatment.
Purpose of the Study:
- To investigate the distinct microbiological and transcriptional profiles of pouchitis and UC.
- To differentiate the pathogenesis of pouchitis from its precursor, UC.
Main Methods:
- Analysis of gut microbiota composition using 16S ribosomal DNA pyrosequencing in stool samples.
- Bioinformatic analysis of transcriptome data from UC and pouchitis patients.
- Comparison of microbial populations and gene expression patterns between patient groups.
Main Results:
- Ulcerative colitis aggravation correlated with decreased microbial diversity and butyrate-producing bacteria.
- Pouchitis showed reduced probiotics, increased Escherichia-Shigella and Ruminococcus gnavus, and multiple infection pathways.
- Transcriptome analysis revealed distinct immune responses in UC (TNF, IL) versus pouchitis (cell cycle regulation, CDK1).
Conclusions:
- Pouchitis and UC display unique gut microbiota disturbances and transcriptome alterations.
- Findings suggest pouchitis possesses a distinct pathogenesis independent of UC.
More Related Videos
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
08:14A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model
Published on: February 28, 2018
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:29Drugs for Treatment of Ulcerative Colitis in IBD